What is a Biopharmaceutical CMO?

A Biopharmaceutical Contract Manufacturing Organization (CMO) provides services to biotechnology and pharmaceutical companies for the production of biopharmaceuticals. These services include cell line development, process development, and commercial manufacturing.

Why are Biopharmaceutical CMOs important?

CMOs are crucial for biotech and pharma companies as they offer expertise, advanced technologies, and capacity for large-scale production, helping companies bring their products to market faster and more efficiently.

How big is the Biopharmaceutical CMO Market?

The global Biopharmaceutical CMO Market size was estimated at USD 18.2 Billion in 2023 and is expected to reach USD 51.5 Billion in 2033.

What is the Biopharmaceutical CMO Market growth?

The global Biopharmaceutical CMO Market is expected to grow at a compound annual growth rate of 12.6%. From 2024 To 2033

Who are the key companies/players in the Biopharmaceutical CMO Market?

Some of the key players in the Biopharmaceutical CMO Markets are Lonza, JRS Pharma, Samsung Biologics, CMC biologics, TOYOBO Co. Ltd., FUJIFILM Bio smith Biotechnologies, Wuxi Biologics, Pantheon, PRA Health Sciences, LabCorp, and Other Key Players.

What services do Biopharmaceutical CMOs offer?

Biopharmaceutical CMOs provide a range of services including cell line development, process development, analytical services, and manufacturing of clinical and commercial-scale biopharmaceuticals.

What recent trends are observed in the Biopharmaceutical CMO market?

Recent trends include increased mergers and acquisitions, expansion of manufacturing facilities, and the launch of innovative biomanufacturing services to meet growing market demands.

How does the Biopharmaceutical CMO market impact drug development?

CMOs help reduce the time and cost of drug development by providing specialized services and scalable manufacturing solutions, enabling biotech and pharma companies to focus on innovation and development.

Global Biopharmaceutical CMO Market by Type (Biologics, Biosimilars), By Service (Manufacturing, Fill & Finish Operations, Analytical & Q.C. studies, Packaging), By Source (Mammalian and Non-mammalian), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Published date: July 2024
Report ID: 96860
Number of Pages: 274
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Lonza Group AG Company Profile
- JRS Pharma
- Samsung Biologics
- CMC Biologics
- TOYOBO Co. Ltd.
- FUJIFILM Biosynth Biotechnologies
- Wuxi Biologics
- Pantheon
- PRA Health Science
- LabCorp
- Other key players

Related Reports

Probiotic Market
Medical Aesthetics Market
Radiopharmaceutical Market
Bronchoscopes Market
Pharmacogenomics Market
Disposable Endoscopes Market
Pharmacovigilance Market
Hair Transplant Market
Cancer Cachexia Market
Sensorimotor Neuropathy Market

Our Clients

Report ID 96860
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (38)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible